Brief: KYORIN Holdings unit grants MSD K.K. manufacturing and marketing rights for medicine of allergic diseases

Kyorin Pharmaceutical

28/09/2016 05:23

Sept 28 (Reuters) - KYORIN Holdings Inc   4569.T : 
     
     
    * Says MSD K.K. received a manufacturing and marketing 
approval for DESALEX Tablets 5mg for the treatment of allergic 
diseases from the co's unit KYORIN Pharmaceutical Co., Ltd. 
     
     
    Source text in Japanese:http://rrd.me/JEhk 
    Further company coverage: 4569.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))